Zimmer Biomet (NYSE:ZBH) announced Tuesday that the EU regulators granted CE Mark certification for the company’s RibFix ...

Zimmer Biomet (NYSE: ZBH) + Zimmer Biomet Holdings, Inc. $112.503 0.58% Open 111.5 Day High 113.6 52 Week High 133.6 52 Week ...

Abbott ABT recently announced CE Mark approval for the Volt Pulsed Field Ablation (“PFA”) system to treat patients battling atrial fibrillation (AFib). The development came earlier than expected, ...

With PFA becoming physicians’ preferred ablation method for treating AFib, Abbott is pushing to catch up with rival systems ...

Abbott Laboratories snagged a CE mark for its Volt pulsed field ablation catheter for atrial fibrillation several months earlier than the mid-year approval expected. The Abbott Park, Ill.-based ...

Newronika announced today that it received CE mark approval for its AlphaDBS device for treating Parkinson's disease.

Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has ...

Abbott (ABT) announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation. With the ...

The company is first rolling out the use of the Volt system among European Union doctors who have already gained experience ...

Zimmer Biomet (ZBH) announced its RibFix Advantage Fixation System has received CE Mark certification – the first CE Mark for an intrathoracic rib fixation system. Discover the latest stocks ...

Abbott's Volt™ PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillation Pulsed field ablation – or PFA – uses high energy ...

Thursday announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation (AFib).